May 12th, 2022 (Earnings Report)Dear Reader,HealthTechMovers.com just identified several healthtech stocks that are expected to release earnings this week.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Athira Pharma
Symbol: ATHA
Recent Price: $$8.42
Average Analyst Price Target: $39.00 (363.18%)
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Thomas Shrader, analyst at BTIG, reiterates coverage on Athira Pharma (ATHA) in the Healthcare sector with a Buy rating and a price target of $ 33 (2 days ago).
Click for complete article >>--------------------------------------------------------------------------
CTI BioPharma
Symbol: CTIC
Recent Price: $$3.55
Average Analyst Price Target: $8.44 (137.75%)
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Benjamin Burnett, analyst at Stifel Nicolaus, reiterates coverage on CTI BioPharma (CTIC) in the Healthcare sector with a Buy rating and a price target of $ 6.2 (1 week ago).
Click for complete article >>--------------------------------------------------------------------------
Knight Therapeutics
Symbol: KHTRF
Recent Price: $$4.05
Average Analyst Price Target: $5.56 (37.28%)
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Justin Keywood, analyst at Stifel Nicolaus, reiterates coverage on Knight Therapeutics (KHTRF) in the Healthcare sector with a Hold rating and a price target of n/a (2 days ago).
Click for complete article >>--------------------------------------------------------------------------
Nkarta
Symbol: NKTX
Recent Price: $$12.43
Average Analyst Price Target: $50.00 (302.25%)
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Dane Leone, analyst at Raymond James, reiterates coverage on Nkarta (NKTX) in the Healthcare sector with a Buy rating and a price target of $ 32 (2 weeks ago).
Click for complete article >>--------------------------------------------------------------------------
Privia Health Group
Symbol: PRVA
Recent Price: $$18.74
Average Analyst Price Target: $37.70 (101.17%)
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Adam Ron, analyst at Bank of America Securities, reiterates coverage on Privia Health Group (PRVA) in the Healthcare sector with a Buy rating and a price target of $ 27 (1 week ago).
Click for complete article >>--------------------------------------------------------------------------
Ventyx Biosciences
Symbol: VTYX
Recent Price: $$13.48
Average Analyst Price Target: $41.60 (208.61%)
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Tiago Fauth, analyst at Credit Suisse, reiterates coverage on Ventyx Biosciences (VTYX) in the Healthcare sector with a Buy rating and a price target of $ 53 (3 days ago).
Click for complete article >>--------------------------------------------------------------------------
Veru
Symbol: VERU
Recent Price: $$8.16
Average Analyst Price Target: $29.20 (257.84%)
Last Year's EPS:
Consensus EPS Forecast:
Expected Earnings Date:
Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on Veru (VERU) in the Healthcare sector with a Buy rating and a price target of $ 24 (14 hours ago).
Click for complete article >>
To Your Financial Future,
The Editor, HealthTechMovers.com
